Grant Pickering - Dec 27, 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
/s/ Ron Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Dec 27, 2021
Transactions value $
$92,995
Form type
4
Date filed
12/28/2021, 03:14 PM
Previous filing
Nov 23, 2021
Next filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $90.2K +50.4K +8.68% $1.79 631K Dec 27, 2021 Direct
transaction PCVX Common Stock Options Exercise $2.84K +1.4K +0.22% $2.03 632K Dec 27, 2021 Direct
holding PCVX Common Stock 356K Dec 27, 2021 By Children's Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -50.4K -15.32% $0.00 278K Dec 27, 2021 Common Stock 50.4K $1.79 Direct F1
transaction PCVX Stock Option (right to buy) Options Exercise $0 -1.4K -0.24% $0.00 594K Dec 27, 2021 Common Stock 1.4K $2.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are fully vested and exercisable.
F2 1/4 of the shares subject to the option vested on July 24, 2019, and 1/48 of the shares vest monthly thereafter.